[
    [
        {
            "time": "2020-10-27",
            "original_text": "Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting",
            "features": {
                "keywords": [
                    "LY-CoV555",
                    "proof of concept",
                    "COVID-19",
                    "neutralizing antibody"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-10-27",
            "original_text": "Eli Lilly Posts Positive Data On Covid-19 Treatment In Phase 2 Trials",
            "features": {
                "keywords": [
                    "Covid-19",
                    "Phase 2 Trials",
                    "Positive Data"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Eli Lilly Posts Positive Data On Covid-19 Treatment In Phase 2 Trials",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-10-27",
            "original_text": "Lilly's Coronavirus Antibody Treatment Found Effective, Safe In Mild-To-Moderate Patients",
            "features": {
                "keywords": [
                    "Coronavirus",
                    "Antibody Treatment",
                    "Effective",
                    "Safe"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Lilly's Coronavirus Antibody Treatment Found Effective, Safe In Mild-To-Moderate Patients",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-10-27",
            "original_text": "Eli Lilly Reports Success With COVID-19 Neutralizing Antibody Treatment",
            "features": {
                "keywords": [
                    "Success",
                    "Neutralizing Antibody",
                    "Treatment"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Eli Lilly Reports Success With COVID-19 Neutralizing Antibody Treatment",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-10-27",
            "original_text": "Lilly and Pfizer Are Testing Treatments for Hospitalized Covid Patients",
            "features": {
                "keywords": [
                    "Lilly",
                    "Pfizer",
                    "Hospitalized",
                    "Covid",
                    "Treatments"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Lilly and Pfizer Are Testing Treatments for Hospitalized Covid Patients",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-10-27",
            "original_text": "Coronavirus update: Operation Warp Speed readies for vaccine as CDC tries to manage expectations",
            "features": {
                "keywords": [
                    "Operation Warp Speed",
                    "vaccine",
                    "CDC",
                    "expectations"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "government"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Coronavirus update: Operation Warp Speed readies for vaccine as CDC tries to manage expectations",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-10-27",
            "original_text": "Dow Jones Rallies 200 Points Ahead Of Fed; Stocks Mixed As Nasdaq Falters",
            "features": {
                "keywords": [
                    "Dow Jones",
                    "Rallies",
                    "Fed",
                    "Stocks Mixed",
                    "Nasdaq"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Dow Jones Rallies 200 Points Ahead Of Fed; Stocks Mixed As Nasdaq Falters",
                "Correlation": 2,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-10-27",
            "original_text": "Eli Lilly Says Antibody Lowers Risk of Hospitalization for Mild COVID-19 Patients",
            "features": {
                "keywords": [
                    "Antibody",
                    "Lowers Risk",
                    "Hospitalization",
                    "Mild COVID-19"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Eli Lilly Says Antibody Lowers Risk of Hospitalization for Mild COVID-19 Patients",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        },
        {
            "time": "2020-10-27",
            "original_text": "Lilly Drug Gets Fast Track to Improve Heart Attack Outcome",
            "features": {
                "keywords": [
                    "Lilly Drug",
                    "Fast Track",
                    "Heart Attack"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Lilly Drug Gets Fast Track to Improve Heart Attack Outcome",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-10-27",
            "original_text": "Eli Lilly Says Covid-19 Treatment Reduces Hospitalizations",
            "features": {
                "keywords": [
                    "Covid-19",
                    "Treatment",
                    "Reduces",
                    "Hospitalizations"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Eli Lilly Says Covid-19 Treatment Reduces Hospitalizations",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        },
        {
            "time": "2020-10-27",
            "original_text": "Shares of Lilly gain as it discloses promising interim findings for COVID-19 antibody treatment",
            "features": {
                "keywords": [
                    "Shares",
                    "Lilly",
                    "gain",
                    "promising interim findings",
                    "COVID-19",
                    "antibody treatment"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Shares of Lilly gain as it discloses promising interim findings for COVID-19 antibody treatment",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-10-27",
            "original_text": "Lilly says antibody reduces need for hospitalization for moderate COVID-19 patients",
            "features": {
                "keywords": [
                    "antibody",
                    "reduces",
                    "hospitalization",
                    "moderate COVID-19"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Lilly says antibody reduces need for hospitalization for moderate COVID-19 patients",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        },
        {
            "time": "2020-10-27",
            "original_text": "The Argus Dividend Growth Portfolio",
            "features": {
                "keywords": [
                    "Argus",
                    "Dividend Growth Portfolio"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "The Argus Dividend Growth Portfolio",
                "Correlation": 1,
                "Sentiment": 5,
                "Importance": 1,
                "Impact": 1,
                "Duration": 2,
                "Entity_Density": 1,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 4,
                "Source_Recency": 5
            }
        }
    ]
]